Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
[Synthesis of optically active 5- (3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride and their beta-adrenergic blocking activities (author's transl)].
1976
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
D002040
Levobunolol
The L-Isomer of bunolol.
AKBeta,Apo-Levobunolol,Betagan,Levobunolol Hydrochloride,Novo-Levobunolol,PMS-Levobunolol,Ultracortenol,Vistagan,W-7000A,ratio-Levobunolol,Apo Levobunolol,ApoLevobunolol,Novo Levobunolol,NovoLevobunolol,PMS Levobunolol,PMSLevobunolol,W 7000A,W7000A,ratio Levobunolol
Related Publications
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
[Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
May 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.
December 1974, Japanese journal of pharmacology,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Syntheses and beta-adrenergic blocking activities of the optical isomers of 8-acetonyloxyl-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril.
August 1981, Chemical & pharmaceutical bulletin,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
[Metabolic fate of carteolol hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride, OPC-1085], a new beta-blocker. V. Identification of metabolites in rat, dog and human (author's transl)].
April 1977, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
[Fluorometric determination of 5-(3-tert-butylamino-2hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085) and structure of fluorescent substance (author's transl)].
January 1977, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
May 1983, Journal of medicinal chemistry,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
January 1977, Clinical and experimental pharmacology & physiology,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
[Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride(OPC-1085) on coronary circulation and myocardial metabolism].
March 1975, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
The inotropic and chronotropic responses of isolated canine atrium to 5-(3-tert.-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol).
January 1979, Arzneimittel-Forschung,
K Yamamoto, and T Uno, and T Ishihara, and K Nakagawa
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
January 1980, Journal of medicinal chemistry,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name